-
-
Neuropsychiatric Symptoms of Dementia, FDA Actions.
-
Once intensive care practices have been well standardized, patient safety becomes one of the biggest issues in the ICU in terms of management of health care quality (affecting the outcomes of patients admitted to the ICUs). The acquisition of nosocomial infections in the ICU is known to significantly affect patient outcomes such as ICU and hospital mortality and length of ICU and hospital stays.
-
This meta-analysis of published trials comparing HMEs and heated humidifiers found a significant reduction in VAP when they were used, particularly among patients who required more than 7 days in the ICU.
-
A fixed combination of the narcotic analgesic oxycodone and the nonsteroidal anti-inflammatory agent ibuprofen has been approved for the short-term treatment of acute moderate-to-severe pain. This first time combination of these 2 agents is marketed by Forest Laboratories as CombunoxTM.
-
Although irritable bowel syndrome is mostly viewed as a nuisance disease without serious consequences, a surprisingly large number of IBS patients may suffer severe depression, hopelessness, and consequential suicidal ideation.
-
The addition of niacin to patients with known CAD on statins raised HDL cholesterol and reduced atherosclerosis progression.
-
A single fecal occult blood test from a digital rectal exam specimen does not provide adequate screening for colorectal neoplasia and cannot replace standard at-home 6-sample fecal occult blood testing.
-
Obesity is an important, potentially modifiable risk factor for AF. The excess risk of AF associated with obesity appears to be mediated by left atrial dilatation. These prospective data raise the possibility that interventions to promote normal weight may reduce the population burden of AF.
-